To investigate the G protein and protein kinase C (PKC) systems during
the initial state of kappa-opioid tolerance, the low K-m GTPase and P
KC activities were measured following repeated treatment of rat with t
he kappa-agonist, U-50,488. In behavioral studies, antinociceptive tol
erance to U-50,488 was developed following 7-day treatment with U-50,4
88. Under these conditions, repeated administration of U-50,488 signif
icantly enhanced the basal low K-m GTPase activity in the pons/medulla
but not in the cortex and midbrain regions. On the other hand, repeat
ed U-50,488 treatment had no effect on PKC activity in cytosol and mem
brane fractions under the calcium-chelating conditions. These results
indicate that repeated administration of kappa-agonist, U-50,488, incr
eases in the basal hydrolysis of GTP to GDP in rat pons/medulla but no
t PKC activity which was observed in the case of repeated administrati
on with morphine in rats.